insights_auto
Why is RKDA down 14.49%?
Dive Deeperchevron_right
RKDA:NASDAQ
Arcadia Biosciences Inc
$0.23
arrow_downward
-14.49%(-0.038) 1D
$0.22
arrow_downward
-2.65% (-0.0060)todayPre-market
Closed: Oct 12, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for RKDA...
Open
$0.26
High
$0.26
Low
$0.21
Mkt. cap
553.48K
Avg. vol.
1.86M
Volume
1.23K
52-wk high
$5.72
52-wk low
$0.21
EPS
-$4.55
Beta
0.55
Shares outstanding
2.41M
No. of employees
8
Open
$0.26
High
$0.26
Low
$0.21
Mkt. cap
553.48K
Avg. vol.
1.86M
Volume
1.23K
52-wk high
$5.72
52-wk low
$0.21
EPS
-$4.55
Beta
0.55
Shares outstanding
2.41M
No. of employees
8
News stories
From web sources and news partners
The Avery Journal-Times
·
41 minutes ago
XCF Global (Nasdaq:SAFX) Announces $12M+ in Gross Product Sales and Shipments of 1.4 Million Gallons of Renewable Diesel in September
MarketBeat
·
3 minutes ago
Syndax Pharmaceuticals (NASDAQ:SNDX) Given Buy Rating at HC Wainwright
The Lufkin Daily News
·
49 minutes ago
S&P 500, Dow futures muted after big bank earnings, chip slide weighs
24/7 Wall St.
·
58 minutes ago
Buffett Says a Know-Nothing Investor Can Beat the Pros. $250 a Month in the S&P 500 Could Turn Into $508,000
Profile
Arcadia Biosciences is a publicly traded American agricultural biotechnology headquartered in Davis, California focused on the development of traits to enhance crop quality and productivity. The company is partly owned by Moral Compass Corporation.
It has developed a reduced-gluten and enhanced starch variety of wheat under the name GoodWheat. Arcadia also has a joint venture with Bioceres called Verdeca, which has developed and is commercializing HB4 technology in soybeans that gained FDA approval in 2017. HB4 soybeans have increased yield up to 30% while being more resistant to abiotic stress such as drought. Wikipedia
About Arcadia Biosciences Inc